![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 22969-22977, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, April 6, 2000, and in revised form, May 9, 2000
The zinc finger protein GATA-1 functions in a
concentration-dependent fashion to activate the transcription
of erythroid and megakaryocytic genes. Less is understood, however,
regarding factors that regulate the GATA-1 gene. Presently
elements within intron 1 are shown to markedly affect its
erythroid-restricted transcription. Within a full-length 6.8-kilobase
GATA-1 gene construct (G6.8-Luc) the deletion of a central
subdomain of intron 1 inhibited transcription GATA factors are a family of nuclear zinc finger DNA-binding
proteins that hierarchically regulate the expression of
lineage-specific target genes (1-6). Structurally, these factors bind
a core GATA motif (within hexameric elements) via two conserved central
Cys2/Cys2 finger domains, but diverge more in
amino- and carboxyl-terminal domains (7, 8). With regards to expression
profiles, GATA-1 levels are highest in erythroid and megakaryocytic
cells (9, 10), and moderate in mast cells, eosinophils, and
multipotential hematopoietic progenitors (11, 12). GATA-2 expression is
highest in hematopoietic stem and progenitor cells, embryonic brain,
endothelial cells, fibroblasts, kidney, liver, and cardiac muscle (13); GATA-3 in T-cells and neuronal tissues (14); GATA-4 in heart and gut
(15); GATA-5 in heart and lung (5); and GATA-6 in heart, smooth muscle,
and gut (16). Via promoter activation and/or gene disruption
experiments, each has been demonstrated to activate target genes that
contribute critically to the development of the above tissues (1-6).
For GATA-1, attenuated expression in chimeric mice deregulates
megakaryocytic progenitor cell proliferation and impairs platelet
production (17), while gene disruption blocks erythroid development at
a penultimate stage (1). In addition, in viral myb-ets transformed
chicken myeloblasts (18) and in murine myeloid FDCER cells (19),
incrementally increased expression of GATA-1 has been shown to activate
megakaryocytic and erythroid gene transcription in a developmentally
stepwise fashion.
Less well defined are regulators of GATA gene expression.
The GATA-1 gene is best studied and first, a
900-bp1 proximal promoter
region 5' to exon 1a has been described which in isolation directs
transcription in erythroleukemic murine erythrolukemic cells (but not
3T3 fibroblasts) in part via two inverted GATA-1 elements (20, 21).
Unlike a yeast artificial chromosome construct containing the
GATA-1 gene locus, however, this proximal promoter failed to
support the expression of a linked GATA-1 cDNA at levels sufficient
to rescue the erythroid differentiation of GATA1-deficient embryonic
stem cells (22). Second, extended GATA-1 gene
Cell Lines--
SKT6 cells (27) were maintained at 37 °C,
7.5% CO2 in Opti-MEM I medium (Life Technologies,
Gaithersburg, MD), 4% fetal bovine serum (Hyclone Laboratories, Logan,
UT). B6SUt.Ep cells (28) were maintained in this medium containing 5%
conditioned medium from WEHI-3B cells as a source of IL3 (29). FDCW2ER
cells and a derived line ectopically expressing GATA-1 (FDCW2ER-GATA1, GATA-1 Promoter Constructs--
Constructs were prepared from a
11.3-kb region of the murine GATA-1 gene (23) which includes
the translational start codon of exon 2, exon 1b, exon 1a, the UAE (at
Transfections and Transcriptional Reporter Assays--
In
transient transfections, exponentially growing cells were adjusted to
3 × 105 c/ml in 6-well plates (3 ml per well). For
SKT6-EE372 and B6SUt.Ep cells, plasmids (6.5 µg of GATA-1 reporter
construct and 1.5 µg of pCMV-SEAP) (Tropix, Bedford, MA) then were
diluted in Opti-MEM I medium (150 µl), incubated SuperFect reagent
(60 µg) (Qiagen, Valencia, CA) for 15 min at 23 °C, and added to
cells. At 48 h of culture, transfected cells were washed and lysed
in reporter buffer (Promega, Madison WI). Cleared samples (10,000 × g for 10 min) were assayed for protein concentration (to
account for a less than 2-fold variability in cell growth, recovery,
and/or lysis), for SEAP activity (CSPD chemiluminescent substrate,
Tropix, Bedford, MA), and for luciferase activity. In transfections of FDCER and FDCER-GATA1 cells, 12 µl of FuGENE-6 reagent (Roche Molecular Biochemicals) was incubated for 5 min in Opti-MEM I (100 µl), combined with plasmid DNAs (1.8 µg of GATA-1 reporter constructs plus 0.2 µg of pCMV-SEAP), and added to cells. At 24 h of culture, protein, luciferase, and SEAP were assayed. 293 cell
lines (30% confluent, 100-mm dishes) were transfected using calcium
phosphate, 4.5 µg of GATA-1 reporter plasmids, and 0.2 µg of
pCMV- Northern and Western Blotting--
RNA was isolated using TRIzol
reagent (Life Technologies), and electrophoresed in
formaldehyde-agarose gels, blotted to Nytran membranes (Schleicher and
Schuell, Keene, NH), and fixed. 32P-Labeled probes were
prepared by random priming using DNA polymerase I (Klenow fragment), 50 µCi of [ In Vivo Footprinting--
Exponentially growing SKT6 cells
(4 × 108) were collected and resuspended in 4 ml of
7% fetal bovine serum in Opti-MEM I media. Methylation was achieved by
incubation for 4 min at 20 °C with either 7 or 21 µl of (10.57 M) DMS (Sigma) per 2 ml of cells, and was terminated by
washing cells twice with 0 °C phosphate-buffered saline. Genomic DNA
was extracted, and methylated guanine (G) residues were hydrolyzed by
incubating 20 µg of DMS-treated genomic DNA with 0.1 M
piperidine for 10 min at 90 °C (31). Control genomic DNA was
extracted, and exposed to DMS and piperidine. 1 µg of DNA was used as
a template for ligation-mediated PCR (34). Complementary strand
synthesis was with primer 1A (5'-GTCTCTCCCTCCATTTCC-3', Tm = 60 °C). Linker ligation was as described
using a modified Mueller and Wold linker (32). PCR amplification of the
double-stranded population was with primer 2A
(5'-ACTGTGTTTCTGTGTTTTTCCTACC-3', Tm = 63 °C). A
third primer (3A: 5'-CTGTGTTTCTCCTACCTTTCTGTGCTTTACC-3', Tm = 67 °C) was end-labeled using T4
polynucleotide kinase (New England Biolabs, Beverly, MA) and
[ Erythroid Splenocytes and ex Vivo Expanded Bone Marrow
Cells--
Erythroid splenocytes were obtained from mice treated
subcutaneously with thiamphenicol as described previously (33). Stem Span medium (Stem Cell Technologies, Vancouver, BC, Canada) (1 × 106 cells/ml initial density) containing murine
interleukin-3 (10 µg/ml) and -6 (10 ng/ml) and mSCF (50 ng/ml)
(granulocyte/macrophage, 7-day culture); hEpo (1 unit/ml), mSCF (100 ng/ml), human insulin-like growth factor-1 (40 ng/ml), 1 µM dexamethasone, and 1 µM Reverse Transcription-PCR Analyses--
cDNA was synthesized
using an oligo(dT) primer and Superscript II RNase H DNA Sequence Analyses--
Cycle sequencing reactions were
performed using 3' BigDye-labeled dideoxynucleotide triphosphates and
an ABI PRISM 377 DNA Sequencer (Perkin-Elmer ABI, Foster City, CA).
Putative elements for transcription factor binding were defined using
Sequence Interpretation Tools software.
In primary analyses of GATA-1 gene subdomains that
affect erythroid-specific transcription, the deletion constructs
illustrated in Fig. 1 were prepared from
a parent construct, G6.8-Luc, and assayed for activity in erythroid
SKT6 cells. Within G6.8-Luc, 6800 bp 5' to exon 1a are retained,
including the UAE and additional upstream sequences. In G4.5-Luc and
G2.5-Luc, upstream sequences of 2300 and 4300 bp are deleted,
respectively. In G6.8-ESI To determine the extent to which the above delineated GATA-1
gene subdomains might regulate transcription selectively in erythroid cells, reporter constructs also were assayed in a uniquely advantageous pair of cell lines, i.e. FDCW2ER and FDCW2ER-GATA-1 cells.
FDCW2ER cells are a well characterized myeloid progenitor cell line in which no expression of GATA-1, EKLF, Epo receptor, or globin gene transcripts is detectable, while FDCW2ER-GATA-1 cells are a derived subline in which the stable expression of exogenous GATA-1 activates endogenous erythroid gene expression, including GATA-1, EKLF, and
Based on the above characterized role for a central subdomain of intron
1 in erythroid-specific transcriptional activity, this region of the
murine GATA-1 gene next was sequenced (Fig. 3). Sequencing revealed first the
occurrence of several GATA elements as well as a CACC element within a
proximal 900-bp region. In addition, positioned in an immediately
upstream region were clusters of seven contiguous consensus GATA
elements (bold and underlined) and four adjacent
Ap1 elements (italicized and underlined). The functional significance of these latter repeated elements next was
tested in three ways. The ability of GATA-1, FOG, or GATA-1 plus FOG to
activate the above described transcriptional reporter constructs in 293 fibroblasts was assessed; repeat domains were assessed for trans-factor
occupancy in erythroid SKT6 cells by in vivo footprinting;
and relative rates of transcription from promoters positioned upstream
of exon 1a versus 1b were assayed.
Intron 1 Elements Promote Erythroid-specific
GATA-1 Gene Expression*
§¶,
§
**
Programs in Genetics and Departments of
Biochemistry & Molecular Biology and § Veterinary
Science, The Pennsylvania State University,
University Park, Pennsylvania 16802
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
10-fold in transiently
transfected erythroid SKT6 cells, and likewise inhibited high-level
transcription in erythroid FDCW2ER-GATA1 cells. In parental myeloid
FDCER cells, however, low-level transcription was largely unaffected by
intron 1 deletions. Within intron 1, repeated GATA and Ap1 consensus
elements in a central region are described which when linked directly
to reporter cassettes promote transcription in erythroid SKT6 and
FDCER-GATA1 cells at high rates. Moreover, GATA-1 activated
transcription from this subdomain in 293 cells, and in SKT6 cells this
subdomain footprinted in vivo. For stably integrated GFP
reporter constructs in erythroid SKT6 cells, corroborating results were
obtained. Deletion of intronic GATA and Ap1 motifs abrogated the
activity of G6.8-pEGFP; activity was decreased by 43 and 56%,
respectively, by the deletion of either motif; and the above 1800-base
pair region of intron 1 per se was transcribed at rates
uniformly greater than G6.8-pEGFP. Also described is the differential
utilization of exons 1a and 1b among primary erythromegakaryocytic and
myeloid cells.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase reporter constructs recently have been tested
in vivo, and an upsteam activating
element (UAE) positioned approximately 2600 bp upstream of
exon 1 was discovered to be required for efficient expression in
erythroid and megakaryocytic cells (23-25). Interestingly, expression
in definitive erythroid cells also was inhibited by the deletion of a
downstream 3900-bp region (including intron 1 and exon 1b) (22), and
within this general region an erythroid-specific hypersensitive site
previously has been mapped (26). Presently, possible contributions of
intron 1 subdomains to high-level erythroid-restricted GATA-1 gene transcription have been investigated further.
For transiently as well as stably transfected reporter constructs, a
central subdomain of intron 1 is shown to be necessary (as well as
sufficient) for high-level transcription in erythroid cells, and to
contain repeat consensus GATA and Ap1 elements which footprint in
vivo. Also examined are rates of transcriptional initiation from
exon 1a versus exon 1b in primary hematopoietic cells. These novel regulatory features of the GATA-1 gene likely exert
important effects on its differential levels of expression among
developmental stages, and hematopoietic lineages.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
maj-globin positive subline) (19) were cultured in
Opti-MEM I containing 8% fetal bovine serum and Epo (25 units/ml). 293 cells and derived cell lines were maintained in Opti-MEM I, 6% fetal
bovine serum.
2.7 to
3.9 kb), and 2.9 kb 5' to the UAE. Constructs G4.5, ESI
3700, and ESI 1800 were prepared by exonuclease III deletion as
follows. A parent construct (G6.8 within pGL2-Basic) (Promega, Madison,
WI) was linearized with KpnI, blunted, and incubated at
32 °C with exonuclease III (50 units/µl). At defined intervals,
products were blunted with S1 nuclease and self-ligated.
Promoter domains then were excised using NotI (engineered
site at exon 2 start codon), were cloned to pGL2-BSBasic
(i.e. pGL2-Basic modified to contain the polylinker region
of pBS-SK+) at SmaI and NotI sites, and sized and
sequenced. G2.5 was prepared by excising a 4200-bp
KpnI-NheI fragment from G6.8, and blunt ending
(and self-ligating) this parent plasmid. ESI 900 was prepared by PCR
using G6.8 as a template and the primers 5'-CAAACTCCTATGGGAGCTGTC-3'
and 5'-CTTTATGTTTTTGGCGTCTTCCA-3'. This PCR product was cloned stepwise
to pCR-Script SK(+) (Stratagene, La Jolla, CA) and to pGL2-BSBasic as a
KpnI-NotI fragment. G6.8 ESI
900 was prepared
by replacing a 3400-bp XbaI-ClaI fragment of G6.8
with a 2450-bp SmaI-ClaI fragment from ESI 900. GFP-linked GATA-1 reporter plasmids were constructed as follow.
G6.8-Luc, ESI 1800-Luc, and
G6.8
[GATA]7
[Ap1]4-Luc were restricted
with NotI, blunt-ended with Klenow, restricted with
KpnI and ligated as a KpnI-SmaI
(blunt) fragment into pEGFP1 (CLONTECH, Palo Alto, CA). G6.8
[GATA]7-EGFP and
G6.8
[Ap1]4-EGFP were constructed by PCR amplification
using G6.8-EGFP as template and pairs of primers (containing engineered
BglII sites) that excluded either the GATA repeats or Ap1
repeats (
[GATA]7 pairs as
5'-GAGATATCCAGGAATACATAGTCTAGAAGAAATTAGTCTAG-3' and
5'-GAAGATCTTCGGAGGTCAGTGGACAAACATGGGTGT-3',
5'-GAAGATCTTCACAGACTGACTGACTGACTGACTGACTGA-3' and
5'-GATCTAGAGTCGCGGCCGCTTTACTTG-3';
[Ap1]4 pairs as
5'-GAAGATCTTCGCAGAAGCACATAAAGATAAAATCTTTGTTTTCAAAGG-3' and
5'-GATCTAGAGTCGCGGCCGCTTTACTTG-3',
5'-GGAATACATAGTCTAGAAATACATAGTCTAG-3' and
5'-GAAGATCTTCGTCTGTCTATCTATCTATCTATCTATCTATC-3'). Products were
cloned (in 3-way XbaI/BglII/NotI
ligations) to pEGFP-1 and were confirmed by sequencing.
gal. At 48 h of culture, luciferase and
-galactosidase activities were assayed. In stable transfections, GFP reporter constructs in pEGFP1 were linearized with XhoI and were
electrotransfected into SKT6 cells using conditions described
previously (27). FOG and GATA-1 were expressed stably in 293 cells from
pEFNeo-FOG (30) and pREP4-GATA1 vectors. pREP4-GATA1 was prepared by
cloning a 1.6-kb XbaI-NotI murine GATA-1 cDNA
from pCINeo-GATA1 (319 to pREP4 (Invitrogen, Palo Alto, CA). Vectors
(15 µg) plus carrier DNA (5 µg) were transfected using calcium
phosphate and stably transfected sublines were selected using G418 (1 mg/ml) and/or hygromycin B (75 µg/ml). Clonal lines (293-GATA1,
293-FOG, and 293-FOG-GATA1) were isolated by limiting dilution. GATA-1
and FOG expression was assayed as described below.
-32P]dATP (3000 Ci/mmol), and 25 ng of the
following cDNA fragments: 1.8-kb KpnI-NotI
fragment of pXMGATA-1 (murine GATA-1) (9), 3.2-kb EcoRI
fragment of pEFneo-FOG (murine FOG) (30), and a 0.8-kb
KpnI-XhoI fragment of pSP-GAPDH (human
glyceraldyhyde phosphate dehydrogenase). Hybridizations were in
QuickHyb solution (Stratagene, La Jolla, CA). In Western blotting,
cells were lysed in 7.5% glycerol, 2.5% SDS, 0.1 M
dithiothreitol, 8.75 mM Tris, pH 6.8 (100 µl/106 cells), and soluble proteins were electrophoresed
and blotted to nitrocellulose. The N6 antibody to GATA-1 (Santa Cruz
Biotechnology, Santa Cruz, CA) was used and detected by enhanced chemiluminescence.
-32P]ATP (Amersham Pharmacia Biotech). The
radiolabeled primer was elongated via five PCR cycles. Products were
resolved in 5% gels and exposed to film. The sequencing ladder was
created using Sequenase (U. S. Biochemicals, Cleveland, OH) and
pCRScript-G (7)/Ap1(4) as a template.
-estradiol (erythroid cells, 3-day culture); murine interleukin-3 (10 ng/ml) and
hTpo (50 ng/ml) (megakaryocytic cells, 4-day culture).
reverse transcriptase (Life Technologies). Products derived from exon
1a versus 1b of endogenous GATA-1 gene were
amplified using the following primers: 5'
GAACTCGTCATACCAGTAA
3'
(exon 1a); 5'
AAAAAGAGGAAATGGAGGAGGC
3' (exon 1b); and
5'
GTGGAATCTGATGGTGAGG
3' (exon 2, used to amplify each product). 1 µCi of [
-32P]dATP (3000 Ci/mmol) was included in
each reaction, and thermal cycles were 1 min at 92 °C, 1 min at
52 °C, 2 min at 72 °C for 32 cycles. Products were
electrophoresed in 5% acrylamide gels and analyzed by autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
900, upstream regions are intact but a
central 900-bp subdomain of intron 1 (bounded by exons 1a and 1b and
designated ESI, erythroid-specific intron) is deleted. Finally, in ESI 3700-Luc, ESI 1800-Luc,
and ESI 900-Luc, subdomains of intron 1 alone are represented, and are
fused to a luciferase cassette immediately upstream from a unique
translational start codon in exon 2 of the GATA-1 gene (as
are all luciferase and GFP reporter constructs). Activities of the
above constructs in transiently transfected SKT6 cells are illustrated
in Fig. 2, upper panel. For
G4.5-Luc, activity reproducibly was observed to be increased 2-fold
over G6.8-Luc upon the deletion of an apparently repressing 2300-bp
region upstream of the UAE. Consistent with the results of in
vivo studies (21, 22) deletion (from G6.8-Luc) of the UAE in
construct G2.5-Luc inhibited transcription in SKT6 cells by
approximately 10-fold (as compared with G4.5). More remarkably, in
G6.8ESI
900 the deletion of a central subdomain of intron 1 inhibited
transcription as severely as the deletion of the UAE (i.e.
10-fold inhibition). In addition, when fused directly to a luciferase
reporter cassette, a proximal 1800-bp region of this intron (construct
ESI 1800-Luc) promoted transcription in transiently transfected SKT6
cells at rates as high as
10-fold above those observed for G6.8-Luc
and G4.5. Within ESI 1800-Luc, the deletion of a distal 900-bp region (yielding the construct ESI 900) abrogated activity, further
delineating strong positively acting elements within intron 1 to a
central subdomain. Finally, in the construct ESI 3700 inclusion of a
further 5' region of intron decreased activity in SKT6 cells,
indicating the possible presence of inhibitory elements within the far
upstream region of intron 1.

View larger version (17K):
[in a new window]
Fig. 1.
GATA-1 gene luciferase reporter
constructs. Diagrammed are GATA-1 gene luciferase
reporter constructs including the deletion mutants G6.8, G4.5, G2.5,
G6.8 ESI
900, and the intron 1-derived constructs ESI-3700, ESI-1800,
and ESI-900. Indexed are select restriction sites, the UAE, a primary
site of transcriptional initiation at exon 1a (Tx+1) and the site of
fusion (within exon 2) of each test construct to a luciferase cassette
(Luc).

View larger version (30K):
[in a new window]
Fig. 2.
Deletion of an intron 1 central subdomain
inhibits high level, erythroid-specific GATA-1 gene
transcription. Erythroid SKT6 cells, erythroid FDCER-GATA-1 cells,
and myeloid FDCER cells were transfected in triplicate with the
GATA-1 gene luciferase reporter deletion constructs G6.8,
G4.5, G2.5, G6.8ESI
900 (left panels), or with the intron
1-derived constructs ESI-3700, -1800, -900 (right panels).
Through co-transfection, pSEAP was used to account for limited
variability in transfections. Graphed for each construct are
transcriptional activities (luciferase units) as mean values ± S.D. Results shown are representative of three independent experiments
(note the differences in ordinate scales for deletion versus
intron-derived constructs).
maj globin (19). In erythroid FDCW2ER-GATA-1 cells,
those GATA-1 gene constructs which possessed high
transcriptional activities in erythroid SKT6 cells (i.e.
G6.8-, G4.5-, and ESI 1800-Luc) likewise were transcribed at high rates
(Fig. 2, center panels). In myeloid FDCW2ER cells, however,
transcription of these constructs was uniformly low (Fig. 2,
lower panels) while activities of constructs G2.5 and ESI
900 were elevated. These results reinforced the above findings in SKT6
cells, and indicate that a central 900-bp domain of intron 1 contains
elements that strongly promote erythroid-restricted GATA-1
gene transcription. In addition, the elevated activities of constructs
G2.5 and ESI 900 in myeloid FDCERW2ER cells at least suggest that
domains
4500 to
2500 and +1800 to +900, while activating in red
cells, might also repress transcription in other lineages. Activities
of the above GATA-1 promoter constructs also were assayed in erythroid
B6SUt.Ep cells (28), and activity profiles were observed to sharply
parallel those observed in SKT6 and FDCW2ER-GATA-1 cells.2

View larger version (44K):
[in a new window]
Fig. 3.
Repeated GATA and consensus Ap1 elements
within intron 1 of the GATA-1 gene. Illustrated
is the sequence of a central to proximal region of intron 1. Indexed
within the proximal (promoter) are 4 consensus GATA motifs
((A/T)GATA(A/G)) and a CACCC box. More centrally located and indexed
are clustered GATA boxes (including 7 consensus elements) and Ap1 boxes
(including 4 adjacent contiguous consensus elements).
For investigations in 293 fibroblasts, GATA-1 and/or FOG were expressed
stably and in the derived cell lines 293-GATA-1, 293-FOG-GATA-1, and
293-FOG, transcription from select transiently transfected GATA-1
reporter constructs was assayed (Fig.
4A). In 293-GATA-1 cells,
GATA-1 per se had little effect on the activities of either G6.8 or G6.8-ESI
900 constructs (the latter of which is designated G6.8
[GATA]7
[Ap]4 based on
sequencing). For the intron 1 construct ESI 1800-Luc, however, rates of
transcription due to GATA-1 expression were increased by approximately
6-fold (see Fig. 4A, second panel and lower summary
panel). Also, in ESI 900-Luc this effect was limited (to
approximately a 2-fold induction) due to the deletion of this intron 1 central subdomain. In 293-GATA-1-FOG cells, the co-expression of FOG
with GATA-1 did not significantly affect the transcription of the
intron 1 constructs ESI 3700, 1800, or 900, but did reproducibly
increase transcription from the GATA-1 gene constructs
G6.8-Luc and G4.5-Luc approximately 2-fold (in 293-FOG cells, FOG alone
did not exert this effect). As a further positive control, 293 sublines
also were transiently transfected with a reporter that contains a
545-bp promoter region of the murine
IIb gene. As shown in Fig.
4A (right panels) GATA-1, as well as GATA-1 plus
FOG, efficiently activated this megakaryocytic promoter. Thus, the
central subdomain of intron 1 which contains repeated GATA and Ap1
elements maps as a functional target for GATA-1-dependent
transcriptional activation (see Fig. 4, lower summary
panel). In Fig. 4, B and C, levels of GATA-1
and FOG expression in stably transfected 293 cells are illustrated. To
further assess the functional importance of cis-elements within intron
1, in vivo footprinting of a region bounding GATA and Ap1
repeats also was performed in SKT6 cells. As shown in Fig.
5, footprinting against
DMS-dependent hydrolysis was observed for a region
extending from nine (of 14) GATA repeats through eight GACA repeats,
and extended 3' through at least four flanking nucleotides (GCAG). This
was observed at two concentrations of DMS (left panel) and in independently repeated experiments. Dideoxy dGTP and dATP sequence reaction products from a cloned intron 1 fragment (primed with an
internal oligo used in genomic footprinting reactions) were used to
index the register of footprinted products. These data indicate stable
occupancy of this intron 1 subdomain in erythroid cells.
|
|
Initially in SKT6 cells and erythroid splenocytes, relative rates of
transcription from initiation sites within exon 1a versus exon 1b within the endogenous GATA-1 gene were next assayed.
Assays were by 32P-reverse transcriptase-PCR using primers
specific for exon 1a versus 1b (for schematics of exons
within the GATA-1, and -2, and -5 genes, see Fig.
6, lower panel). In both SKT6
cells and erythroid splenocytes, transcription was primarily from exon
1a yet also initiated at appreciable rates from exon 1b (Fig. 6, upper panels). Next, exon 1a and 1b-derived transcripts were
assayed in marrow cells expanded ex vivo under culture
conditions selective for the propagation of CFUe, CFU-Meg, or
granulocytes/monocytes (Fig. 6, center panel). In
marrow-derived erythroid and megakaryocytic cells, relative frequencies
of exon 1a versus 1b-derived transcripts were highly similar
to those observed in SKT6 cells and erythroid splenocytes. In primary
granulocyte/monocytic cells, however, transcripts from exon 1b somewhat
unexpectedly were detected at levels comparable to those in erythroid
and megakaryocytic cells (while no exon 1a-derived transcripts were
detected). Sequencing confirmed the identity of this PCR product. Thus,
transcription from initiation sites in exon 1a occurs at high levels in
cells that develop within erythroid or megakaryocytic lineages. In
addition, initiation from this exon may be selectively repressed in
alternate hematopoietic progenitor cells while initiation from exon 1b
does not appear to be subject to this differential regulation.
|
Finally, the potential concern that activities of transiently
transfected reporter constructs may not necessarily reflect their
capacities to promote transcription from chromosomally integrated sites
was addressed. Specifically, to further test roles for intron 1 features in regulating transcription, five related GATA-1
gene constructs were linked (at exon 2) to a GFP cassette and were electrotransfected into SKT6 cells. Stably transfected constructs included G6.8-EGFP,
G6.8
[GATA]7
[Ap1]4-EGFP (deletion of
intron 1 GATA and Ap1 repeats), G6.8
[GATA]7-EGFP
(deletion of repeated consensus GATA elements), G6.8
[Ap1]4-EGFP (deletion of repeated consensus Ap1
elements), and ESI-1800-EGFP (proximal 1800 bp of intron 1 linked
directly to a GFP cassette) (Fig. 7). As
shown for two representative clones (paired left and
right panels, Fig. 8A) (and as was observed above
in transient transfections), the deletion of both GATA and Ap1 elements
in G6.8
[GATA]7
[Ap1]4EGFP inhibited
transcription from stable integrated constructs to low levels
(i.e. levels approximating those of the negative control promoter-less construct EGFP1). By comparison, the deletion of only
GATA repeats (in G6.8
[GATA]7-EGFP) or Ap1 repeats (in
G6.8
[Ap1]4-EGFP) inhibited transcription among clones
studied to 43 and 56% of G6.8-EGFP levels, respectively. Finally,
expression from construct ESI-1800-EGPF uniformly was somewhat greater
than G6·8-EGFP, despite the absence of all upstream components
(including the UAE). Results for stably integrated (and single-copy)
constructs are summarized in Fig. 8B (and are illustrated as
median EGFP fluorescence among representative clones). These results
provide further evidence that the above described elements within
intron 1 exert important effects on GATA-1 gene
transcription.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
While investigations in several model systems have established
GATA-1 as a hierarchical regulator of erythroid, megakaryocytic, and
eosinophilic gene expression (1-19), factors that control GATA-1
expression in these (and in other lineages at lower levels) are only
partially defined. With respect to the GATA-1 gene, previous studies have demonstrated: 1) that a 900-bp promoter which occurs 5' to
exon 1a contains two key GATA elements, and efficiently supports
transcription in transiently transfected murine erythrolukemic cells
(but not in 3T3 fibroblasts) (20, 21); 2) that erythroid-specific transcription of reporter constructs in mice also depends upon an
activation domain positioned 2600 bp upstream from exon 1a (including a
key GATA box within a 149-bp core of this UAE) (23-25); and 3) that
the deletion of an extended region spanning intron 1 and exon 1b also
inhibited transcription in mice of
-galactosidase reporter
constructs containing intact UAE and exon 1a promoter domains (23-25).
This latter observation, together with preliminary characterizations of
a hypersensitive site within intron 1 (26) and S1 nuclease
mapping of transcription from exon 1b (20), prompted the present
investigations of intron 1 substructure, its role in directing
high-level erythroid-specific transcription, and its apparent effects
on transcription from initiation sites in exon 1a and 1b.
Structure-function features of intron 1 that merit attention are first, a 900-bp region immediately 5' to exon 1b which alone supported low-level transcription in erythroid cells, yet somewhat higher level transcription in myeloid FDCER cells (see Figs. 1-3). Based on the occurrence in this functional ESI-900 promoter of several consensus GATA elements as well as a CACC box (which likewise occur in the previously described promoter 5' to exon 1a) (20, 21), it was anticipated that its activity in erythroid cells might be higher. Erythroid activity, however, proved to require linkage to the central region of intron 1. This GATA and Ap1 repeat-containing region (in ESI-1800-Luc and -EGFP constructs) interestingly also strongly repressed transcription in myeloid FDCER cells. These findings at least suggest roles for this central region in recruiting not only erythroid activators, but possibly repressors in non-erythroid cells. Finally, the 1900-bp distal region of intron 1 (as linked to ESI-1800 in ESI-3700-Luc) repressed transcription specifically in erythroid SKT6 and FDCER-GATA1 cells. Inspection of this distal region, however, revealed essentially no consensus elements for transfactor binding. In contrast is the striking occurrence of the above central repeat GATA and Ap1, and data also indicate that this region is transactivated by GATA-1 in 293 cells and occupied in erythroid SKT6 cells in vivo. Specific activities exerted by subsets of repeat elements merit further study, but by analogy it is interesting to consider that essential clustered GATA elements also recently have been described within the divergently transcribed niiA and niaD genes of Aspergillus (34). In this system, disruption of these elements (or of the GATA gene, Area) blocks chromatin remodeling at these sites, and severely inhibits niiA and niaD transcription. In addition, within the short arm of chromosome Y, GATA repeats within a p17 subregion of an M34 repeat (including 12 contiguous elements in as many as 300 repeated M34 domains) also have been speculated to regulate testes-specific decondensation (35).
As investigated within the context of full-length and maximally active
reporter constructs (and as analyzed in both transient and stable
transfections), an important role for the central subregion of intron 1 in directing erythroid-specific GATA-1 gene expression is
also presently described. Here dramatic losses in activity due to the
deletion of both GATA and Ap1 elements simply but importantly reveal
requirements for this intronic region in erythroid transcription. Mechanistically, this might involve effects on transcription initiated at exon 1b, 1a, or both. The deletion of this intron region inhibited overall luciferase and GFP expression from exon 2
10-fold, while levels of transcripts derived from exon 1b in erythroid cells accounted
for only 10% (or less) of total levels. It therefore is concluded that
transcription from both exon 1a and b depends upon the intactness of
intron 1. Such effects of intron elements on transcription are not
common, yet have been well documented in other systems. Examples
include a tissue-specific reduction in mRNA stability upon the
deletion of intron 1 of the
1-collagen gene (36),
attenuated nuclear export of mitogen-regulated proliferin transcripts
(37), and roles for intron 1-3 of the mouse thymidine kinase gene in
markedly modulating transcript initiation (38). In the narrowed context
of erythroid genes, several examples also exist wherein introns can
regulate lineage-specific transcription. In the Epo receptor gene, an
erythroid-specific DNase I hypersensitive site has been mapped to
intron 1, and this intron was shown to enhance transcription 4-fold and
to contain two key GATA-1-binding sites (39). In the human adult
-
and
-globin genes, important roles for introns in transcriptional
regulation also have been described. In the adult
-globin gene, two
DNase I-hypersensitive sites have been mapped within intron II (
IVS2) that contain four GATA-1 binding sites (40) and integrity of
IVS2 has been shown to be important for transcription (possibly via
interactions with elements in the locus control region) (41). Finally,
in the human
-globin gene cluster, a key upstream hypersensitive site, HS-40, interestingly lies within an intron of an anonymous but
widely expressed gene (42) and integrity of this site likewise is
essential for high-level
-globin gene expression in erythroid cells
(43). Within the presently studied GATA-1 gene, whether integrity of intron 1 supports transcript stability, transport, and/or
initiation is under active investigation (as is the possible lineage
specificity of this effect).
A final interesting feature of GATA-1 gene transcription is the
observed utilization of exon 1b (but not 1a) in primary
granulocytic/monocytic cells (see Fig. 6). In these
granulocytes/monocytes cells, levels of exon 1b-derived transcripts
were shown to approximate those in primary erythroid and megakaryocytic
cells, while little to no exon 1a-derived transcripts were detected.
This observation at least suggests that exon 1b might be selectively
utilized in non-erythromegakaryocytic cells to provide for low-level
GATA-1 expression. By comparison, in at least two related
GATA genes, GATA-2 and -5,
differential expression from similarly distributed exons recently
has been reported. In the murine GATA-2 gene Minegishi et al. (13) have demonstrated the occurrence of two
functional promoters upstream from exons 1S and 1G which are positioned
in close parallel to exons 1a and 1b of the murine GATA-1
gene (see Fig. 6). Transcription from exon 1S was observed only in
Sca-1+/c-Kit+ hematopoietic progenitor cells,
and repeat elements for GATA binding were discovered in the promoter
flanking this exon. In the chicken GATA-5 gene,
transcription also is initiated from two distinct exons, and in
embryonic heart, transcripts initiate from both exons while in adult
heart initiation is only from 1b (44). Thus, whether transcription of
the GATA-1 gene from exons 1a versus 1b might
also be regulated differentially during erythroid development likely
merits further investigation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Stuart Orkin for the generous provision of the murine full-length GATA-1 promoter. We also thank Amy Wrentmore for generating 293-derived cell lines, and Amgen (Drs. Steve Elliott and Robert Pacifici) for the provision of recombinant human Epo.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant R01 HL44491 (to D. M. W.) and a Sigma Xi grant-in-aid (to D. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence of intron 1 subdomains reported in this submitted to GenBankTM/EBI Data Bank under accession number X57530.
¶ Contributed equally to the results in this report.
** To whom correspondence should be addressed: 115 William L. Henning Bldg., The Pennsylvania State University, University Park, PA 16802. Tel.: 814-865-0657; Fax: 814-863-6140; E-mail: dmw1@psu.edu.
Published, JBC Papers in Press, May 12, 2000, DOI 10.1074/jbc.M002931200
2 D. Seshasayee, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: bp, base pair(s); embryonic stem, UAE, upstream activating element; SEAP, secreated alkaline phosphatase; EGFP, enhanced green fluorescent protein; FOG, friend of GATA-1; DMS, dimethyl sulfate; Epo, erythropoietin; SCF, stem cell factor; Tpo, thrombopoetin; ESI, erythroid-specific intron; EKLF, erythroid Krüppel-like factor; CFU, colony forming unit; kb, kilobase(s); PCR, polymerase chain reaction.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S. F., D'Agati, V., Orkin, S. H., and Costantini, F. (1991) Nature 349, 257-260 |
| 2. | Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., and Orkin, S. H. (1994) Nature 371, 221-226 |
| 3. | Ting, C.-N., Olson, M. C., Barton, K. P., and Leiden, J. M. (1996) Nature 384, 474-478 |
| 4. | Heikinheimo, M., Scandrett, J. M., and Wilson, D. B. (1994) Dev. Biol. 164, 361-373 |
| 5. | Morrisey, E. E., Ip, H. S., Tang, Z., Lu, M. M., and Parmacek, M. S. (1997) Dev. Biol. 183, 21-36 |
| 6. | Morrisey, E. E., Ip, H. S., Lu, M. M., and Parmacek, M. S. (1996) Dev. Biol. 177, 309-322 |
| 7. | Pedone, P. V., Omichinski, J. G., Nony, P., Trainor, C., Gronenborn, A. M., Clore, G. M., and Felsenfeld, G. (1997) EMBO J. 16, 2874-2882 |
| 8. | Morrisey, E. E., Ip, H. S., Tang, Z., and Parmacek, M. S. (1997) J. Biol. Chem. 272, 8515-8524 |
| 9. | Martin, D. I., Zon, L. I., Mutter, G., and Orkin, S. H. (1990) Nature 344, 444-447 |
| 10. | Yamamoto, M., Ko, L. J., Leonard, M. W., Beug, H., Orkin, S. H., and Engel, J. D. (1990) Genes Dev. 4, 1650-1662 |
| 11. | Sposi, N. M., Zon, L. I., Care, A., Valtieri, M., Testa, U., Gabbianelli, M., Mariani, G., Bottero, L., Mather, C., and Orkin, S. H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6353-6357 |
| 12. | Leonard, M., Brice, M., Engel, J. D., and Papayannopoulou, T. (1993) Blood 82, 1071-1079 |
| 13. | Minegishi, N., Ohta, J., Suwabe, N., Nakauchi, H., Ishihara, H., Hayashi, N., and Yamamoto, M. (1998) J. Biol. Chem. 273, 3625-3634 |
| 14. | Pandolfi, P. P., Roth, M. E., Karis, A., Leonard, M. W., Dzierzak, E., Grosveld, F. G., Engel, J. D., and Lindenbaum, M. H. (1995) Nat. Genet. 11, 40-44 |
| 15. | Laverriere, A. C., MacNeill, C., Mueller, C., Poelmann, R. E., Burch, J. B., and Evans, T. J. (1994) J. Biol. Chem. 269, 23177-23184 |
| 16. | Narita, N., Heikinheimo, M., Bielinska, M., White, R. A., and Wilson, D. B. (1996) Genomics 36, 345-348 |
| 17. | Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., and Orkin, S. H. (1997) EMBO J. 16, 3965-3973 |
| 18. | Kulessa, H., Frampton, J., and Graf, T. (1995) Genes Dev. 9, 1250-1262 |
| 19. | Seshasayee, D., Gaines, P., and Wojchowski, D. M. (1998) Mol. Cell. Biol. 18, 3278-3288 |
| 20. | Tsai, S. F., Strauss, E., and Orkin, S. H. (1991) Genes Dev. 5, 919-931 |
| 21. | Nicolis, S., Bertini, C., Ronchi, A., Crotta, S., Lanfranco, L., Moroni, E., Giglioni, E. B., and Ottolenghi, S. (1991) Nucleic Acids Res. 19, 5285-5291 |
| 22. | Simon, M. C., Pevny, L., Wiles, M. V., Keller, G., Costantini, F., and Orkin, S. H. (1992) Nat. Genet. 1, 92-98 |
| 23. | McDevitt, M. A., Fujiwara, Y., Shivdasani, R. A., and Orkin, S. H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7976-7981 |
| 24. | Onodera, K., Takahashi, S., Nishimura, S., Ohta, J., Motohashi, H., Yomogida, K., Hayashi, N., Engel, J. D., and Yamamoto, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4487-4492 |
| 25. | Nishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C., and Yamamoto, M. (2000) Mol. Cell. Biol. 20, 713-723 |
| 26. | Ronchi, A., Ciro, M., Cairns, L., Cross, M., Ghysdael, J., and Ottolenghi, S. (1997) Genes Funct. 1, 245-258 |
| 27. | Gregory, R. C., Jiang, N., Todokoro, K., Crouse, J., Pacifici, R. E., and Wojchowski, D. M. (1998) Blood 92, 1104-1118 |
| 28. | Quelle, F. W., and Wojchowski, D. M. (1991) J. Biol. Chem. 266, 609-614 |
| 29. | Ihle, J. N., Keller, J., Greenberger, J. S., Henderson, L., Yetter, R. A., and Morse, H. C. (1982) J. Immunol. 29, 1377-1383 |
| 30. | Tsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., and Orkin, S. H. (1997) Cell 90, 109-119 |
| 31. | Strauss, E. C., and Orkin, S. H. (1997) Methods: A Companion Methods Enzymol. 11, 164-170 |
| 32. | Mueller, P. R., and Wold, B. (1989) Science 246, 780-786 |
| 33. | Miller, C. P., Liu, Z. Y., Noguchi, C. T., and Wojchowski, D. M. (1999) Blood 94, 3381-3387 |
| 34. | Muro-Pastor, M. I., Gonzalez, R., Strauss, J., Narendja, F., and Scazzocchio, C. (1999) EMBO J. 18, 1584-1597 |
| 35. | Singh, L., Panicker, S. G., Nagaraj, R., and Majumdar, K. C. (1994) Nucleic Acids Res. 22, 2289-2295 |
| 36. | Hormuzdi, S. G., Penttinen, R., Jaenisch, R., and Bornstein, P. (1998) Mol. Cell. Biol. 18, 3368-3375 |
| 37. | Malyankar, U. M., Rittling, S. R., and Denhardt, D. T. (1996) J. Cell. Biochem. 60, 198-210 |
| 38. | Sutterluety, H., Bartl, S., Doetzlhofer, A., Khier, H., Wintersberger, E., and Seiser, C. (1998) Nucleic Acids Res. 26, 4989-4995 |
| 39. | Heberlein, C., Fischer, K. D., Stoffel, M., Nowock, J., Ford, A., Tessmer, U., and Stocking, C. (1992) Mol. Cell. Biol. 12, 1815-1826 |
| 40. | Jackson, C. E., O'Neill, D., and Bank, A. (1995) J. Biol. Chem. 270, 28448-28456 |
| 41. | Collis, P., Antoniou, M., and Grosveld, F. (1990) EMBO J. 9, 233-240 |
| 42. | Bernet, A., Sabatier, S., Picketts, D. J., Ouazana, R., Morle, F., Higgs, D. R., and Godet, J. (1995) Blood 86, 1202-1211 |
| 43. | Jarman, A. P., Wood, W. G., Sharpe, J. A., Gourdon, G., Ayyub, G. H., and Higgs, D. R. (1991) Mol. Cell. Biol. 11, 4679-4689 |
| 44. | MacNeill, C., Ayres, B., Laverriere, A. C., and Burch, J. B. (1997) J. Biol. Chem. 272, 8396-8401 |
This article has been cited by other articles:
![]() |
K. D. Dyer, M. Czapiga, B. Foster, P. S. Foster, E. M. Kang, C. M. Lappas, J. M. Moser, N. Naumann, C. M. Percopo, S. J. Siegel, et al. Eosinophils from Lineage-Ablated {Delta}dblGATA Bone Marrow Progenitors: The dblGATA Enhancer in the Promoter of GATA-1 Is Not Essential for Differentiation Ex Vivo J. Immunol., August 1, 2007; 179(3): 1693 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi and M. Yamamoto Regulation of GATA1 Gene Expression J. Biochem., July 1, 2007; 142(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bose, C. Fugazza, M. Casalgrandi, A. Capelli, J. M. Cunningham, Q. Zhao, S. M. Jane, S. Ottolenghi, and A. Ronchi Functional Interaction of CP2 with GATA-1 in the Regulation of Erythroid Promoters Mol. Cell. Biol., May 15, 2006; 26(10): 3942 - 3954. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hisatsune, K. Matsumura, M. Ogawa, A. Uemura, N. Kondo, J. K. Yamashita, H. Katsuta, S. Nishikawa, T. Chiba, and S.-I. Nishikawa High level of endothelial cell-specific gene expression by a combination of the 5' flanking region and the 5' half of the first intron of the VE-cadherin gene Blood, June 15, 2005; 105(12): 4657 - 4663. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Wong, J. Lin, B. G. Forget, D. M. Bodine, and P. G. Gallagher Sequences Downstream of the Erythroid Promoter Are Required for High Level Expression of the Human {alpha}-Spectrin Gene J. Biol. Chem., December 31, 2004; 279(53): 55024 - 55033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishikawa, M. Kobayashi, A. Masumi, S. E. Lyons, B. M. Weinstein, P. P. Liu, and M. Yamamoto Self-Association of Gata1 Enhances Transcriptional Activity In Vivo in Zebra Fish Embryos Mol. Cell. Biol., November 15, 2003; 23(22): 8295 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Miller, D. W. Heilman, and D. M. Wojchowski Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms Blood, February 1, 2002; 99(3): 898 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Rowntree, G. Vassaux, T. L. McDowell, S. Howe, A. McGuigan, M. Phylactides, C. Huxley, and A. Harris An element in intron 1 of the CFTR gene augments intestinal expression in vivo Hum. Mol. Genet., July 1, 2001; 10(14): 1455 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, K. Nishikawa, and M. Yamamoto Hematopoietic regulatory domain of gata1 gene is positively regulated by GATA1 protein in zebrafish embryos Development, June 15, 2001; 128(12): 2341 - 2350. [Abstract] [Full Text] [PDF] |
||||